Evidence map›Paper›PMID 36349888›Full record

ArticleMolecular pharmaceutics2022

Development of Proanthocyanidin-Loaded Mesoporous Silica Nanoparticles for Improving Dental Adhesion.

Ahmad Alkhazaleh, Sundes Elfagih, Leela Raghava Jaidev Chakka, Steven R Armstrong, Carissa L Comnick, Fang Qian, Aliasger K Salem, C Allan Guymon, Amanda J Haes, Cristina M P Vidal

Abstract read
In one paragraph

Article in Molecular pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ahmad AlkhazalehDepartment of Operative Dentistry, College of Dentistry, The University of Iowa, 801 Newton Road, Iowa City, Iowa52242, United States.
Sundes ElfagihDepartment of Operative Dentistry, College of Dentistry, The University of Iowa, 801 Newton Road, Iowa City, Iowa52242, United States.
Leela Raghava Jaidev ChakkaDepartment of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, The University of Iowa, 180 S Grand Ave, Iowa City, Iowa52242, United States.
Steven R ArmstrongDepartment of Operative Dentistry, College of Dentistry, The University of Iowa, 801 Newton Road, Iowa City, Iowa52242, United States.ORCID 0000-0003-4746-0576
Carissa L ComnickDivision of Biostatistics and Computational Biology, College of Dentistry, The University of Iowa, 801 Newton Road, Iowa City, Iowa52242, United States.
Fang QianDivision of Biostatistics and Computational Biology, College of Dentistry, The University of Iowa, 801 Newton Road, Iowa City, Iowa52242, United States.
Aliasger K SalemDepartment of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, The University of Iowa, 180 S Grand Ave, Iowa City, Iowa52242, United States.ORCID 0000-0002-1923-6633
C Allan GuymonDepartment of Chemical and Biochemical Engineering, College of Engineering, The University of Iowa, 3100 Seamans Center, Iowa City, Iowa52242, United States.ORCID 0000-0002-3351-9621
Amanda J HaesDepartment of Chemistry, College of Liberal Arts and Sciences, The University of Iowa, E331 Chemistry Building, Iowa City, Iowa52242, United States.ORCID 0000-0001-7232-6825
Cristina M P VidalDepartment of Operative Dentistry, College of Dentistry, The University of Iowa, 801 Newton Road, Iowa City, Iowa52242, United States.ORCID 0000-0003-4345-8487

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Brandi Janssen · 1990 to 2026
$40.5M
NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

Dentin biomodification is a promising approach to enhance dental tissue biomechanics and biostability for restorative and reparative therapies. One of the most active dentin tissue biomodifiers is proanthocyanidin (PAC)-rich natural extracts, which are used in the dental bonding procedure in combination with resin-based adhesives (RBAs). This study aimed to investigate the use of mesoporous silica nanoparticles (MSNs) for the sustained delivery of PACs for dentin biomodification as a novel drug-delivery system for dental applications. The effects of the incorporation of MSN functionalized with 3-aminopropyltriethoxysilane (APTES) and loaded with PAC into an experimental RBA were assessed by characterizing the material mechanical properties. In addition, the immediate and long-term bonding performance of an experimental resin-based primer (RBP) containing MSN-APTES loaded with PAC was also evaluated. For that, different formulations of RBA and RBP were prepared containing 20% w/v MSN-APTES loaded with PAC before or after functionalization (MSN-PAC-APTES and MSN-APTES-PAC, respectively). The incorporation of MSN-APTES-PAC did not negatively impact the degree of conversion or the overall mechanical properties of the RBA. However, adding MSN-PAC-APTES resulted in inferior mechanical properties of the experimental RBA. In the adhesion studies, APTES-functionalized MSN was successfully added to an experimental RBP for drug-delivery purposes without compromising the bond strength to the dentin or the failure mode. Interestingly, the sequence of surface functionalization with APTES resulted in differences in the bonding performance, with better long-term results for RBP containing MSN loaded with PAC after functionalization.

Indexed as

NanoparticlesProanthocyanidinsPropylaminesSilanesSilicon Dioxideamino-propyl-triethoxysilaneProanthocyanidinsPropylaminesSilanesSilicon DioxideDental AdhesionDental AdhesivesDentinDentin BiomodificationMesoporous Silica NanoparticlesProanthocyanidins

Identifiers

PMID36349888
PMCPMC9727728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.